For most people with epilepsy, the right medication controls their seizures. Life adjusts, and with good medical management, seizures become infrequent or stop altogether.
For approximately one in three people with epilepsy, this does not happen. Seizures continue despite trying multiple medications, at adequate doses, over a sustained period. This is drug-resistant epilepsy – and it is not a dead end, even though it can feel like one.
This guide explains what drug-resistant epilepsy is, why it occurs, what the consequences of leaving it uncontrolled are, and what treatment options – including surgical options – exist for Sri Lankan patients.
What Is Drug-Resistant Epilepsy?
Drug-resistant epilepsy – also called refractory epilepsy or pharmacoresistant epilepsy – is defined by the International League Against Epilepsy (ILAE) as the failure of adequate trials of two tolerated, appropriately chosen, and correctly used anti-seizure medications to achieve sustained seizure freedom.
This definition is specific and important:
- The medications must have been chosen appropriately for the patient’s seizure type – not all anti-seizure medications work for all seizure types
- They must have been taken at adequate doses for a sufficient period
- Both medications must have failed – not just been poorly tolerated or inadequately dosed
The two-drug threshold is clinically significant because the evidence shows that once two appropriately chosen medications have failed, the probability of achieving seizure freedom by adding further medications is relatively low – typically around 5 to 10 percent with each additional drug tried.
Drug-resistant epilepsy is not a failure of the patient or the doctor. It is a recognised biological phenomenon in which the underlying cause of the epilepsy makes it inherently less responsive to the mechanisms by which anti-seizure medications work.
How Is Drug-Resistant Epilepsy Diagnosed?
The diagnosis of drug-resistant epilepsy is primarily clinical – based on the history of medications tried, the seizure frequency and type, and confirmation that medications were given appropriate trials.
Before concluding that epilepsy is truly drug-resistant, several alternative explanations for continued seizures should be excluded:
Incorrect Diagnosis
Not all episodes that look like seizures are epileptic seizures. Cardiac events, panic attacks, and dissociative episodes (psychogenic non-epileptic seizures, or PNES) can mimic epilepsy. If the original diagnosis was incorrect, anti-seizure medication will not work – not because the epilepsy is drug-resistant, but because the episodes are not epileptic.
Video-EEG monitoring – in which seizures are recorded simultaneously on video and EEG – is the gold standard for confirming the diagnosis and characterising the seizure type.
Incorrect Medication Choice
Some anti-seizure medications are syndrome-specific. For example, sodium channel blockers (such as carbamazepine) can worsen certain types of generalised epilepsy. If the wrong medication has been used for the wrong seizure type, apparent drug resistance may simply reflect incorrect medication selection.
Poor Medication Adherence
Seizures that continue despite medication may in some cases reflect inconsistent medication taking rather than true drug resistance. This is assessed as part of the clinical history.
Underlying Cause Not Addressed
In some cases, epilepsy persists because an underlying structural cause – a brain lesion, a tumour, a vascular malformation – has not been identified or treated. Identifying a structural cause is one of the most important steps in evaluating drug-resistant epilepsy.
Why Does Epilepsy Become Drug-Resistant?
The biological mechanisms of drug resistance in epilepsy are an active area of research. Several hypotheses have been proposed:
Pharmacokinetic Resistance
Some patients over-express certain proteins (such as P-glycoprotein) that actively pump anti-seizure medications out of brain tissue before they can reach therapeutic concentrations at the seizure focus. This reduces the effective drug concentration at the site where it needs to act.
Pharmacodynamic Resistance
Changes in the targets that anti-seizure medications act on – such as mutations in sodium or potassium channels – can reduce the medication’s effectiveness at those targets.
Structural Causes
Certain structural brain abnormalities are inherently associated with drug-resistant epilepsy. The most important of these for surgical planning is hippocampal sclerosis – scarring of the hippocampus in the temporal lobe, which is the most common identifiable cause of drug-resistant focal epilepsy and the lesion with the best surgical outcomes.
Other structural causes associated with drug resistance include:
- Focal cortical dysplasia – an area of abnormally developed cortex
- Cavernous malformations
- Low-grade brain tumours
- Post-traumatic or post-infectious scarring
Network-Level Resistance
In some cases, epilepsy becomes drug-resistant because the seizure network has become entrenched and widely distributed across the brain, making pharmacological suppression difficult regardless of the medication used.
What Are the Consequences of Uncontrolled Seizures?
The impact of ongoing uncontrolled seizures extends far beyond the seizures themselves:
Physical Risks
- Injury during seizures – falls, burns, drowning, and road traffic accidents are the most common causes of seizure-related injury and death
- SUDEP (Sudden Unexpected Death in Epilepsy) – the most serious risk associated with uncontrolled epilepsy. SUDEP is defined as sudden, unexpected, non-traumatic, non-drowning death in a person with epilepsy, in whom post-mortem examination reveals no other cause. The risk of SUDEP is significantly higher in patients with frequent tonic-clonic seizures than in those who are seizure-free
- Status epilepticus – a prolonged seizure or series of seizures without recovery between them. A medical emergency that carries risk of brain injury and death if not treated promptly
Cognitive and Developmental Consequences
- Repeated seizures – particularly in children – can cause progressive cognitive impairment. In children with drug-resistant epilepsy, the developing brain is particularly vulnerable to the effects of ongoing seizure activity
- Cognitive side effects of multiple anti-seizure medications compound the neurological impact of the seizures themselves
- Educational and developmental progress is impaired in children with frequent uncontrolled seizures
Psychosocial Consequences
- Restrictions on driving – in most countries, a defined seizure-free period is required before driving is permitted
- Limitations on employment – particularly in roles involving operation of machinery, working at heights, or other safety-sensitive activities
- Social isolation and stigma
- Depression and anxiety – significantly more common in people with epilepsy than in the general population, and further elevated in those with drug-resistant disease
- Dependence on caregivers – particularly in patients with frequent or severe seizures
Quality of Life
Patients with drug-resistant epilepsy consistently report significantly lower quality of life than those who are seizure-free. The unpredictability of seizures – never knowing when the next one will occur – creates a constant state of anxiety and restriction that affects every aspect of daily life.
What Are the Treatment Options for Drug-Resistant Epilepsy?
Further Medication Trials
Before concluding that all medication options have been exhausted, a review by an epilepsy specialist is important to confirm that the most appropriate medications for the specific seizure type and epilepsy syndrome have been tried. Newer anti-seizure medications – including cenobamate, brivaracetam, and lacosamide – have demonstrated efficacy in some patients with drug-resistant focal epilepsy who had not responded to older medications.
Dietary Therapies
The ketogenic diet – a high-fat, low-carbohydrate diet that alters the brain’s energy metabolism – has demonstrated efficacy in reducing seizure frequency in children with drug-resistant epilepsy, and is used in adults as well. Modified versions including the modified Atkins diet are more practical for some patients. Dietary therapies require close medical supervision.
Epilepsy Surgery
For appropriately selected patients, surgery offers the best chance of achieving seizure freedom in drug-resistant epilepsy – significantly better than any additional medication trial. Surgery is not a last resort for desperate cases. It is an evidence-based treatment option that, when applied to the right patient at the right time, produces outcomes that no medication can match.
Neuromodulation Devices
For patients who are not surgical candidates for resective surgery, neuromodulation devices offer an alternative:
- Vagus nerve stimulation (VNS) – a device implanted under the skin that sends regular electrical pulses to the brain via the vagus nerve. Typically reduces seizure frequency by 50 percent or more in responders
- Responsive neurostimulation (RNS) – a device implanted in the skull that detects abnormal electrical activity and delivers targeted stimulation to interrupt seizures before they fully develop
- Deep brain stimulation (DBS) – electrical stimulation of the anterior thalamic nucleus, which is part of the seizure network
Who Is a Candidate for Epilepsy Surgery?
Surgical candidacy requires a careful evaluation. General criteria include:
- Confirmed diagnosis of epilepsy with drug-resistant focal seizures – seizures originating from a specific, identifiable brain region
- Two or more appropriately chosen anti-seizure medications have failed to achieve seizure freedom
- A clearly identifiable seizure focus – a consistent region of the brain from which all or the majority of seizures originate
- The seizure focus is located in a brain region where surgery can be performed without unacceptable risk to essential neurological function
- The patient is medically fit for surgery
- The patient and family have realistic expectations about what surgery can and cannot achieve
Importantly, surgery is not restricted to the most severe cases. The evidence consistently shows that outcomes from epilepsy surgery are better when surgery is performed earlier in the course of drug-resistant epilepsy – before years of uncontrolled seizures have caused additional cognitive and psychological harm. A patient who has been on two medications without seizure freedom deserves a surgical evaluation, not a third, fourth, or fifth medication trial as a reflex response.
What Does the Pre-Surgical Evaluation Involve?
The pre-surgical evaluation for drug-resistant epilepsy treatment in India at Amrita Hospitals is comprehensive and follows a structured protocol:
Phase 1 – Non-Invasive Evaluation
- Video-EEG monitoring – the patient is admitted for continuous EEG recording while their typical seizures are captured on video. This allows the clinical team to correlate the electrical signature of the seizures with their visible manifestation, confirming the seizure type and identifying the likely seizure onset zone
- High-resolution MRI – specifically optimised epilepsy-protocol MRI to identify structural abnormalities. A normal routine MRI does not exclude structural lesions detectable by dedicated epilepsy MRI
- PET scan – fluorodeoxyglucose PET measures glucose metabolism in the brain. The seizure focus typically shows reduced metabolism between seizures (the interictal period), helping to confirm and localise the focus
- SPECT scan – ictal SPECT (performed during a seizure) shows increased blood flow at the seizure onset zone. Comparison with a baseline interictal SPECT (subtraction SPECT, or SISCOM) provides additional localising information
- Neuropsychological testing – a detailed assessment of memory, language, attention, and executive function. This serves two purposes: it identifies areas of functional vulnerability that must be protected during surgery, and it provides a baseline against which post-operative cognitive function can be compared
Phase 2 – Invasive Monitoring (Where Required)
When non-invasive tests do not clearly localise the seizure focus, or when the focus is near areas of critical brain function, invasive monitoring is required:
- Stereo-EEG (SEEG) – multiple depth electrodes are inserted through small holes in the skull using robotic stereotactic guidance, allowing recording from deep brain structures. Amrita Hospitals uses ROSA robotic guidance for SEEG electrode implantation, providing the precision required for accurate placement
- Subdural grid electrodes – placed on the brain surface to provide high-resolution mapping of cortical function and seizure onset
Functional Mapping
For seizure foci located near areas responsible for language, movement, or memory, additional mapping procedures confirm the safety boundaries of the proposed resection:
- Functional MRI (fMRI) – identifies brain regions activated by language and motor tasks
- Wada test (intracarotid amobarbital procedure) – each hemisphere is temporarily anaesthetised in sequence to assess language dominance and memory function
- Cortical stimulation mapping – during invasive monitoring, electrical stimulation of specific electrode contacts identifies their proximity to eloquent cortex
What Types of Surgery Are Available?
Resective Surgery
The most common form of epilepsy surgery. The brain tissue identified as the seizure focus is surgically removed. Types include:
- Temporal lobectomy – the most commonly performed epilepsy surgery, used for temporal lobe epilepsy. Removal of the anterior temporal lobe, including the hippocampus, in patients with hippocampal sclerosis. Seizure freedom rates of 60 to 70 percent are well-documented in this group
- Selective amygdalohippocampectomy – a more targeted approach removing only the hippocampus and amygdala, preserving more of the temporal lobe
- Lesionectomy – removal of a specific structural lesion – focal cortical dysplasia, cavernoma, or low-grade tumour – identified as the seizure focus
- Extratemporal resection – removal of seizure-generating tissue outside the temporal lobe
Disconnection Surgery
Used when the seizure focus involves a large area that cannot be safely resected, or when seizures arise from an entire hemisphere:
- Corpus callosotomy – division of the corpus callosum, the structure connecting the two hemispheres, reducing the spread of seizures from one side to the other. Particularly effective for drop attacks (atonic seizures)
- Hemispherotomy or hemispherectomy – disconnection or removal of an entire cerebral hemisphere, used when one hemisphere is severely dysfunctional and generating widespread seizures
Laser Interstitial Thermal Therapy (LITT)
A minimally invasive technique in which a laser probe is inserted into the brain through a small hole and used to thermally ablate the seizure focus under MRI guidance. Used for hippocampal sclerosis, hypothalamic hamartomas, and small deep lesions that are difficult to access through open surgery.
What Are the Outcomes of Epilepsy Surgery?
Outcomes depend on the type of surgery, the location and nature of the seizure focus, and the presence of an identifiable structural lesion. Evidence-based outcome expectations:
- Temporal lobectomy for hippocampal sclerosis – approximately 60 to 70 percent of patients achieve Engel Class I outcome (seizure-free or only rare seizures) at long-term follow-up
- Lesionectomy for focal cortical dysplasia or cavernoma – outcomes depend on completeness of resection. Complete removal of the lesion is associated with significantly better outcomes
- Extratemporal resection – generally lower seizure-freedom rates than temporal surgery, though meaningful reduction in seizure frequency and severity is common
- Corpus callosotomy – does not typically achieve seizure freedom but substantially reduces the frequency and severity of drop attacks, which are among the most dangerous seizure types
- VNS – typically achieves a 50 percent or greater reduction in seizure frequency in approximately 50 percent of patients who receive it. Complete seizure freedom is less common
Amrita Hospitals has performed India’s largest number of minimally invasive epilepsy surgeries, reflecting the institutional depth of experience in this subspeciality that directly influences patient outcomes.
Why Do Sri Lankan Patients Choose India for Drug-Resistant Epilepsy Treatment?
- Amrita Hospitals has conducted India’s largest series of minimally invasive epilepsy surgeries – institutional volume in epilepsy surgery is directly associated with better outcomes
- Full evaluation programme – video-EEG, high-resolution epilepsy MRI, PET, SPECT, neuropsychological testing, fMRI, Wada test, and SEEG with robotic guidance
- ROSA robotic system for SEEG electrode implantation and other stereotactic procedures – the same robotic platform used for Asia’s first robotic DBS implantation
- Full range of surgical options from temporal lobectomy to laser ablation and neuromodulation devices
- Dedicated epilepsy programme with epileptologists, neurosurgeons, neuropsychologists, and neuroradiologists working as an integrated team
- Awareness gap – as Amrita’s neurosurgeons have noted, one of the most significant barriers to better outcomes in drug-resistant epilepsy across South Asia is that patients are not told surgical options exist. A formal surgical evaluation is a step many patients who would benefit from it have never been offered
For more context on the surgical and neurological capabilities at Amrita Hospitals, our article on epilepsy surgery in India for Sri Lankan patients covers the surgical pathway in full detail.
To explore the full range of neurosciences services, visit neurology and brain treatment options in India for Sri Lankan patients.
How Do Sri Lankan Patients Access Treatment in India?
- Gather your existing medical records – EEG reports, MRI scans, medication history, seizure diary if available, and any specialist neurology letters
- Share these with Amrita Info Centre Sri Lanka for forwarding to the epilepsy programme at Amrita Hospitals
- Receive an initial assessment on likely surgical candidacy and recommended evaluation steps
- Travel to Amrita Hospitals for the Phase 1 pre-surgical evaluation – this typically requires a hospital admission of 1 to 2 weeks for video-EEG monitoring
- Based on evaluation results, the surgical team discusses the appropriate treatment option and expected outcomes
For guidance on the visa process, our article on the Complete Guide to Medical Visa for India from Sri Lanka covers documentation requirements and application steps.
For a complete checklist of documents to prepare before travel, our article on documents you need to travel to India for medical treatment from Sri Lanka covers all categories in detail.
Frequently Asked Questions
How do I know if my epilepsy qualifies as drug-resistant? Drug-resistant epilepsy is defined as failure of two appropriately chosen, correctly used anti-seizure medications to achieve seizure freedom. If you are still having seizures after adequate trials of two medications appropriate for your seizure type, a formal surgical evaluation is warranted. Your neurologist can confirm whether your history meets the clinical definition.
Is epilepsy surgery safe? All surgery carries risk. Epilepsy surgery-specific risks depend on the location of the seizure focus and the type of procedure planned. Risks include infection, bleeding, and neurological deficits if the resection involves or is adjacent to functional brain areas. These risks are carefully assessed during the pre-surgical evaluation, and the surgical plan is designed to maximise the chance of seizure freedom while minimising neurological risk.
Will I still need medication after surgery? Most patients continue anti-seizure medication for at least 1 to 2 years after surgery, regardless of seizure outcome. Medication is gradually tapered under specialist supervision if seizure freedom is maintained. Some patients achieve complete medication freedom over time; others continue on reduced doses.
Can children with drug-resistant epilepsy have surgery? Yes. Epilepsy surgery in children with drug-resistant epilepsy is an important and evidence-based treatment. Early surgical intervention – before prolonged uncontrolled seizures cause additional cognitive and developmental harm – is associated with better long-term outcomes. Amrita Hospitals has experience in paediatric epilepsy surgery.
What if the evaluation shows I am not a surgical candidate? If the pre-surgical evaluation concludes that resective surgery is not appropriate, the epilepsy team will discuss alternative options including neuromodulation devices (VNS, RNS, or DBS), dietary therapy, or newer anti-seizure medications. A thorough evaluation that concludes surgery is not the right option is still a valuable outcome – it closes one pathway clearly and redirects the focus to the most appropriate alternatives.
How long will I need to stay in India for the evaluation and surgery? The Phase 1 non-invasive evaluation typically requires 1 to 2 weeks for video-EEG monitoring. If Phase 2 invasive monitoring is needed, a second admission of 1 to 2 weeks may follow. Surgery itself, and the post-operative recovery period, typically requires a further 2 to 3 weeks in India. The total duration depends on the complexity of the evaluation and whether invasive monitoring is required.
Conclusion
Drug-resistant epilepsy treatment in India offers Sri Lankan patients access to a comprehensive epilepsy surgery programme – one that combines a full diagnostic evaluation pathway with the full range of surgical and neuromodulation treatment options, at a centre with India’s largest experience in minimally invasive epilepsy surgery.
For Sri Lankan patients who have been living with uncontrolled seizures despite medication, a formal surgical evaluation is not a radical step. It is the clinically appropriate next step – and for many patients, it is the step that changes everything.
Amrita Info Centre Sri Lanka is ready to support Sri Lankan patients through that process from Colombo.